Bal Pharma Limited
General Updates
01 / The disclosure
What the company shared
Dividend Payment Update - Intimation regarding disbursement of final dividend for the FY 2025 26 and withholding of dividend in respect of shareholders with incomplete KYC/bank details or invalid, blocked or closed bank accounts
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
Numbers found in document text 2 matches
Automatic text matches, not verified financial metrics. A match may come from a table heading or reporting year. Expand it to inspect the surrounding text and original page.
₹1.20Page 1
We wish to inform you that the Members of Bal Pharma Limited (“the Company”), at their 39th Annual General Meeting held on Thursday, September 24, 2026, approved a final dividend of ₹1.20 per equity share of ₹10 each for the financial year 2025–26.
View source page₹10Page 1
We wish to inform you that the Members of Bal Pharma Limited (“the Company”), at their 39th Annual General Meeting held on Thursday, September 24, 2026, approved a final dividend of ₹1.20 per equity share of ₹10 each for the financial year 2025–26.
View source pageThe evidence
Read the source excerpts
01Sub: Dividend Payment Update - Intimation regarding disbursement of final dividend for the FY 2025–26 and withholding of dividend in respect of shareholders with incomplete KYC/bank details or invalid, blocked or closed bank accounts
Page 1
02We wish to inform you that the Members of Bal Pharma Limited (“the Company”), at their 39th Annual General Meeting held on Thursday, September 24, 2026, approved a final dividend of ₹1.20 per equity share of ₹10 each for the financial year 2025–26.
Page 1
03The Company has deposited the declared dividend amount into its designated bank account within the prescribed timeline and has completed the disbursement of the final dividend on October 9, 2026, to eligible shareholders whose names appeared in the Registe r of Members or the records of the Depositories as on the record date, i.e., September 17, 2026.
Page 1
04The dividend was remitted through electronic modes, including NACH/NECS/direct bank remittance, wherever valid bank account details were available.
Page 1
05Shareholders are requested to verify the credit of the final dividend in their respective bank accounts.
Page 1
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106815553
- First collected
- 13 Oct 2026, 12:15 IST
- PDF extraction
- extracted · 1 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- cc682d593c76c80f60d5aef0c3d830296991bd5461ab3394bdc84613787ce0d5